Olfactory DisorderProspeRo'ScentNCT06456008
Prospective Registery of Smell/Taste Clinic Ear/Nose/Throat
An observational study of Olfactory Disorder and Taste Disorders, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.
Trial summary
Smell/taste disorders are common conditions with a significant impact on quality of life. In September 2021, a specific consultation for patients with smell and taste disorders was initiated at the ENT-HNS (ear, nose, and throat, head and neck surgery) department of UZ Leuven, partly in light of post-COVID-19 related… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Olfactory Disorder, Taste Disorders, Smell Dysfunction
- How many people
- 500 participants
- Where
- 1 siteBelgium
- Study dates
- 6 Dec 2022to 31 Dec 2035
- How long will I take part?
- 5 Years
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Study population: Patients consulting for chemosensory dysfunction
Who may be able to join
- The psychophysical testing as well as the questionnaires require a cooperative participant who can understand and follow instructions and communicate their choices.
- Informed consent is necessary upon participation for prospective registry.
- There are no exclusion criteria related to sex, gender, or ethnicity. There are no exclusion criteria related to medical history or prior treatments.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Belgium1 site, 1 recruiting
- Recruiting
UZ/KU Leuven
Leuven, Vlaams-Brabant, 3000
Marnick Clijsters, 003216348044, marnick.clijster@gmail.com
Laura van Gerven
About this study
Official title: Prospective Registry of Outcome and Correlates of Chemosensory Dysfunction at the Smell & Taste Clinic of UZ Leuven
Smell/taste disorders are common conditions with a significant impact on quality of life. In September 2021, a specific consultation for patients with smell and taste disorders was initiated at the ENT-HNS (ear, nose, and throat, head and neck surgery) department of UZ Leuven, partly in light of post-COVID-19 related smell disorders.
With this observational ambidirectional study, the investigators aim to better map smell/taste disorders in the Belgian/Flemish population. Using standard-of-care diagnostic tests and structured questionnaires, the investigators strive to gain more insight into the severity, impact, and progression/prognosis of smell/taste disorders.
- Conditions
- Olfactory Disorder, Taste Disorders, Smell Dysfunction, Smell Disorder
- Being tested
- Standard of care
- Medical subject headings
- Taste Disorders, Olfaction Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard of careOther
Standard of care
What is being measured
The primary outcome is the main question the study is designed to answer.
Chemosensory function
Measured: Observational up to 5 years follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jun 2024
- Study start6 Dec 2022
- Primary completion1 Jan 2027 (estimated)
- Study completion31 Dec 2035 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Olfactory DisorderStudies of the same condition, open and under way.
- More trials run by Universitaire Ziekenhuizen KU LeuvenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 500 participants (estimated)
- Target duration
- 5 Years
Sponsor and investigators
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06456008
- Sponsor's protocol ID
- S67158
- Acronym
- ProspeRo'Scent
- Status last verified
- Dec 2025
- First submitted
- 6 Jun 2024
- Last updated
- 18 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No